CMS Off-Label Coverage Decision For Colorectal Cancer Rx Coming Soon

The Centers for Medicare & Medicaid Services expects to release proposed national coverage determinations on off-label use of colorectal cancer drugs in the "near future," CMS Chief Medical Officer Sean Tunis, MD, said Sept. 30 at a CMS workshop in Baltimore